Friends of the Global Fight: Vigilance in Tackling Drug Resistance in the Global Battle Against HIV
In this blog post, the third in a series of posts exploring the threat that drug resistance poses to HIV/AIDS, TB, and malaria efforts, Mark P. Lagon, chief policy officer, and John McMannis, communications manager, both at Friends of the Global Fight, discuss how “an increase in [antiretroviral (ARV)] drug resistance is posing a significant threat to progress to date, and to our ability to end the [HIV/AIDS] epidemic.” The authors conclude, “[W]ith strategic investment, the Global Fund can build on its existing strategy of working hand-in-hand on Country Operational Plans and implementation with the U.S. President’s Emergency Plan for AIDS Relief, and place countries on the best possible footing to fight drug resistance in HIV” (1/5).